Related references
Note: Only part of the references are listed.RIPK2 NODs to XIAP and IBD
Yusuf Topal et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: A bioinformatics and systems biology approach
Md Al-Mustanjid et al.
GENOMICS (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
Ricard Garcia-Carbonell et al.
FRONTIERS IN IMMUNOLOGY (2019)
Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells
Nian-Kang Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility
Masafumi Ota et al.
ONCOLOGY LETTERS (2018)
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis
Alaa Zare et al.
CANCERS (2018)
RIP kinases as modulators of inflammation and immunity
Sudan He et al.
NATURE IMMUNOLOGY (2018)
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Alison E. Freimund et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
Reto S. Kohler et al.
GYNECOLOGIC ONCOLOGY (2017)
Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOTARGET (2017)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Ellen L. Goode et al.
JAMA ONCOLOGY (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer
Diana P. English et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
Andrew McPherson et al.
NATURE GENETICS (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
Yu Yu et al.
CANCER CELL (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Nirmala Chandralega Kampan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Primary Urethral Clear-Cell Adenocarcinoma Comprehensive Analysis by Surgical Pathology, Cytopathology, and Next-Generation Sequencing
Rohit Mehra et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer
Pierre-Emmanuel Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone
Dana M. Roque et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer
Macarena Guirado et al.
HUMAN IMMUNOLOGY (2012)
Ovarian Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
Robert J. Morgan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
β3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
David A. Tumbarello et al.
MOLECULAR CANCER (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
Hanbo Chen et al.
BMC BIOINFORMATICS (2011)
Cytoscape Web: an interactive web-based network browser
Christian T. Lopes et al.
BIOINFORMATICS (2010)
GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor
Davis Sean et al.
BIOINFORMATICS (2007)
Share Paper
